Ushering in a new era with Antiviral COVID-19 Treatments
We have officially entered a new era in the age of COVID-19 with the approval and administration of new antiviral COVID-19 treatments, particularly Merck’s Molnupiravir and Pfizer’s Paxlovid, meant to treat people who have tested positive for COVID-19, but have not yet been hospitalized.These antiviral treatments will be the key to us moving forward in COVID world for both vaccinated and unvaccinated people fighting COVID infection, as they will reduce risk of severe, life-threatening disease b
6/14 Presentation: “COVID-19: Prevention and Treatment in Vulnerable Populations”
Le Dr Brian Conway dirigera une discussion sur le COVID-19 parrainée par AstraZeneca ce mardi 14/06.Quand : 14 juin 2022 de 12h à 13h PTIl s’agit d’une réunion médicale non promotionnelle pour discuter de la prévention et du traitement du COVID-19 dans un format basé sur des cas.Le but de cette présentation est de :Définir les options de prévention et de traitement de la COVID-19 actuellement disponibles Discuter et débattre des options de prévention et de traitement dans les groupes immunodépri
The Return of Conference Season
Dr. Conway speaking at AMMI 2022 in Vancouver. Spring has sprung, and as we enter a new phase of endemic COVID-19, that means that conferences are (finally!) back on, and in person — for the most part, at least. VIDC’s Dr. Brian Conway has already begun travelling, speaking at AMMI 2022 in Vancouver (our home base) as well as Toronto; and soon Quebec, London, and more. We are excited to once again share our research and knowledge with our peers in the medical science community. More details soo
2021: A Unique World Hepatitis Day
Vancouver Infectious Diseases Centre (VIDC) is committed to eliminating viral Hepatitis by 2030. From testing to increasing awareness, find out how you can join our fight on World Hepatitis Day.